Lv64
2810 积分 2023-09-04 加入
Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma
27天前
已完结
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
1个月前
已完结
Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC
1个月前
已完结
Molecular mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
1个月前
已完结
MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients
1个月前
已完结
Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma
1个月前
已完结
Germline mutations in HRAS proto-oncogene cause Costello syndrome
1个月前
已关闭
RAS oncogenes: the first 30 years
1个月前
已完结
Targeting RAS in neuroblastoma: Is it possible?
1个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
1个月前
已完结
皖公网安备34019202002308
